Executive Committee Member, South Asia Pediatric Association (SAPA), Bangladesh
Background: Critical congenital heart disease (CCHD) remains an important and potentially preventable cause of neonatal morbidity and mortality. Clinical examination alone may fail to identify affected newborns before hospital discharge. Pulse oximetry, when combined with routine clinical examination, provides a feasible opportunity for earlier detection. However, screening can improve outcomes only when positive results lead to timely diagnosis, referral and definitive intervention. Bangladesh recorded a neonatal mortality rate of 20 per 1,000 live births in 2023, against its Sustainable Development Goal (SDG) 2030 target of 12. This presentation examines an evidence-informed framework for integrating clinical screening workflows with health policy to strengthen CCHD detection and care in Bangladesh and South Asia.
Methods: A structured narrative review was undertaken of systematic reviews, diagnostic accuracy studies, South Asian neonatal screening programs, congenital heart disease registries, health-system assessments and national SDG indicators. Evidence was synthesized to identify the clinical, operational, financial and policy requirements for implementing and scaling universal newborn pulse oximetry screening.
Results: International evidence demonstrates that pulse oximetry has a pooled sensitivity of 76.5% and specificity of 99.9% for detecting CCHD, supporting its use alongside clinical examination. In a North Indian study involving 19,009 newborns, combining pulse oximetry with clinical examination increased sensitivity for critical heart disease from 11.5% to 84.6%. A prospective registry across 47 hospitals in Kerala identified 72% of critical cases through pulse oximetry, while highlighting early mortality and challenges in neonatal stabilization and transport. In Bangladesh, 79% of congenital cardiac surgical centers and 94% of reported operations were concentrated in Dhaka, demonstrating geographical disparities in access to specialist cardiac care. These findings highlight the need to link screening with timely echocardiographic confirmation, structured referral, neonatal stabilization and affordable definitive treatment.
Conclusion: A phased, nurse-led screening programs at 24–48 hours of life, combining pre-discharge pulse oximetry with clinical examination, should be integrated into newborn care pathways. Standardized screening algorithms, teleechocardiography, regional referral networks, financial protection and a national birth-defects registry are essential to ensure that early detection translates into equitable access to life-saving treatment. Coordinated clinical and policy action is critical to improving neonatal outcomes and advancing progress towards SDG 2030 targets.
Keywords: Critical Congenital Heart Disease; Newborn Screening; Pulse Oximetry; Neonatal Mortality; Health
Policy; Bangladesh; South Asia
Prof. (Dr.) Manzoor Hussain is a distinguished Bangladeshi Pediatrician with over 40 years of experience in Pediatric Medicine, Pediatric Cardiology and Pediatric Infectious Diseases. He is President of the Bangladesh Society of Pediatric Infectious Disease (BSPID), a Standing Committee Member of ASPID and ISTP, and Executive Committee Member of SAPA. He previously served as Director and Professor at Bangladesh Shishu Hospital and Institute and President of the Bangladesh Pediatric Association and Pediatric Cardiac Society of Bangladesh. A Fellow of all three UK Royal Colleges and FRCPCH, he has authored six books and published over 80 scientific papers. He received the APPA Outstanding Pediatrician Award in 2024.
© 2026 Mathews International LLC. All rights reserved.